Wynzora ® (calcipotriene/betamethasone dipropionate) – New drug approval
July 22, 2020 - MC2 Therapeutics announced the FDA approval of Wynzora (calcipotriene/betamethasone dipropionate) cream, for the topical treatment of plaque psoriasis in patients 18 years of age and older.
Download PDF
